Q3 2024 |
129 |
$228M |
+$60.6M |
-$3.93M |
+$56.7M |
POWW, META, AVGO, MRK, LMT
|
13F-HR |
10/8/2024, 10:27 AM |
Q2 2024 |
91 |
$166M |
+$5.25M |
-$60.1M |
-$54.8M |
POWW, MRK, META, AVGO, BJ
|
13F-HR |
7/9/2024, 05:29 PM |
Q1 2024 |
129 |
$222M |
+$13.8M |
-$17.2M |
-$3.44M |
POWW, MRK, META, AVGO, NTAP
|
13F-HR |
4/11/2024, 12:59 PM |
Q4 2023 |
128 |
$209M |
+$5.15M |
-$10.2M |
-$5.01M |
POWW, MRK, BX, META, STX
|
13F-HR |
1/8/2024, 01:34 PM |
Q3 2023 |
126 |
$195M |
+$4.07M |
-$7.39M |
-$3.32M |
POWW, MRK, BX, META, AZN
|
13F-HR |
11/8/2023, 03:56 PM |
Q2 2023 |
133 |
$206M |
+$8.48M |
-$10.5M |
-$2.03M |
POWW, MRK, META, AZN, LMT
|
13F-HR |
7/26/2023, 01:09 PM |
Q1 2023 |
129 |
$196M |
+$14.5M |
-$14.5M |
-$4.33K |
POWW, MRK, BJ, LMT, MCD
|
13F-HR |
4/12/2023, 11:09 AM |
Q4 2022 |
127 |
$191M |
+$6.36M |
-$12.7M |
-$6.32M |
POWW, MRK, ABBV, UNH, LMT
|
13F-HR |
1/17/2023, 05:07 PM |
Q3 2022 |
126 |
$185M |
+$8.26M |
-$6.9M |
+$1.36M |
POWW, MRK, BJ, UNH, ABBV
|
13F-HR |
11/16/2022, 01:50 PM |
Q2 2022 |
130 |
$202M |
+$8.06M |
-$15.7M |
-$7.64M |
POWW, MRK, VRTX, ABBV, UNH
|
13F-HR |
7/20/2022, 12:28 PM |
Q1 2022 |
131 |
$236M |
+$17.6M |
-$17.9M |
-$360K |
POWW, MRK, ABBV, VRTX, AVGO
|
13F-HR |
5/2/2022, 11:00 AM |
Q4 2021 |
130 |
$249M |
+$17.6M |
-$31.6M |
-$14M |
POWW, BX, AVGO, MRK, RCM
|
13F-HR |
3/15/2022, 04:13 PM |
Q3 2021 |
131 |
$247M |
+$26.8M |
-$37.6M |
-$10.7M |
POWW, BX, GRMN, MRK, BJ
|
13F-HR |
12/2/2021, 12:35 PM |
Q1 2021 |
130 |
$251M |
+$52.6M |
-$24.6M |
+$28M |
POWW, RCM, MRK, GRMN, BJ
|
13F-HR |
6/21/2021, 02:21 PM |
Q4 2020 |
120 |
$213M |
+$60.9M |
-$11.9M |
+$49M |
MRK, RCM, JNJ, BMY, GRMN
|
13F-HR |
3/9/2021, 03:20 PM |
Q3 2020 |
90 |
$153M |
+$6.98M |
-$10.9M |
-$3.89M |
MRK, BMY, JNJ, BJ, D
|
13F-HR |
12/14/2020, 10:14 AM |
Q2 2020 |
90 |
$150M |
+$20.3M |
-$70.8M |
-$50.5M |
MRK, BMY, JNJ, D, BJ
|
13F-HR |
8/3/2020, 05:12 PM |
Q1 2020 |
82 |
$176M |
+$20.9M |
-$52.4M |
-$31.4M |
PCYO, MRK, DLR, QTS, CCI
|
13F-HR |
5/13/2020, 01:35 PM |
Q4 2019 |
92 |
$240M |
+$16.8M |
-$22.7M |
-$5.96M |
PCYO, MRK, BMY, AZN, EIX
|
13F-HR |
1/16/2020, 01:20 PM |
Q3 2019 |
93 |
$233M |
+$20M |
-$31.4M |
-$11.4M |
PCYO, MRK, EIX, EBIXQ, MDP
|
13F-HR |
10/23/2019, 01:07 PM |
Q2 2019 |
97 |
$246M |
+$25.9M |
-$22.6M |
+$3.31M |
EBIXQ, JAZZ, MRK, PCYO, JNJ
|
13F-HR |
8/6/2019, 12:42 PM |
Q1 2019 |
94 |
$235M |
+$39.4M |
-$36.8M |
+$2.57M |
CSCO, MRK, JAZZ, IAC, CCI
|
13F-HR |
4/15/2019, 01:44 PM |
Q4 2018 |
93 |
$211M |
+$20.6M |
-$42.3M |
-$21.8M |
ABBV, MRK, CSCO, IAC, PCYO
|
13F-HR |
1/15/2019, 02:56 PM |
Q3 2018 |
93 |
$267M |
+$31.3M |
-$33.1M |
-$1.8M |
ABBV, MRK, PFG, JAZZ, EBIXQ
|
13F-HR |
10/16/2018, 11:21 AM |
Q2 2018 |
93 |
$255M |
+$36M |
-$34.9M |
+$1.09M |
ABBV, JAZZ, PFG, CSCO, MRK
|
13F-HR |
7/25/2018, 01:32 PM |
Q1 2018 |
89 |
$252M |
+$23.4M |
-$31.6M |
-$8.19M |
ABBV, PFG, JAZZ, CSCO, CY
|
13F-HR |
4/20/2018, 11:53 AM |
Q4 2017 |
97 |
$270M |
+$9.53M |
-$23.2M |
-$13.7M |
ABBV, DLR, PFG, CSCO, MDP
|
13F-HR |
1/19/2018, 11:44 AM |
Q3 2017 |
99 |
$278M |
+$23.3M |
-$23.5M |
-$138K |
ABBV, DLR, PFG, HBI, MRK
|
13F-HR |
10/12/2017, 10:37 AM |
Q2 2017 |
97 |
$267M |
+$40M |
-$32.6M |
+$7.39M |
ABBV, PFG, BIP, MRK, MDP
|
13F-HR |
7/18/2017, 01:25 PM |
Q1 2017 |
90 |
$253M |
+$45.5M |
-$43.8M |
+$1.65M |
PFG, ABBV, BIP, JNJ, MDP
|
13F-HR |
4/26/2017, 02:04 PM |
Q4 2016 |
92 |
$240M |
+$27.2M |
-$14.7M |
+$12.4M |
PFG, ABBV, T, JNJ, BIP
|
13F-HR |
2/6/2017, 05:02 PM |
Q3 2016 |
86 |
$226M |
+$33.3M |
-$35.9M |
-$2.67M |
PFG, ABBV, BIP, JNJ, T
|
13F-HR |
11/9/2016, 01:58 PM |
Q2 2016 |
81 |
$222M |
+$25.8M |
-$33M |
-$7.18M |
PFG, ABBV, BGEPF, JNJ, T
|
13F-HR |
7/28/2016, 03:10 PM |
Q1 2016 |
81 |
$223M |
+$19.8M |
-$22.8M |
-$2.96M |
PFG, ABBV, BGEPF, VZ, OTEX
|
13F-HR |
5/9/2016, 02:52 PM |
Q4 2015 |
78 |
$205M |
+$19.2M |
-$33.1M |
-$13.8M |
VIA, NDAQ, DLR, ABBV, PFG
|
13F-HR |
2/4/2016, 12:09 PM |
Q3 2015 |
81 |
$229M |
+$17.2M |
-$13.4M |
+$3.8M |
PFG, VIA, BGEPF, ABBV, NDAQ
|
13F-HR |
11/10/2015, 01:34 PM |
Q2 2015 |
80 |
$256M |
+$34.1M |
-$26M |
+$8.04M |
PFG, ABBV, BGEPF, CAG, DLR
|
13F-HR |
7/30/2015, 02:03 PM |
Q1 2015 |
82 |
$244M |
+$15M |
-$30M |
-$15M |
ABBV, VZ, BIP, MDP, CAG
|
13F-HR |
5/7/2015, 12:54 PM |
Q4 2014 |
82 |
$254M |
+$20.7M |
-$26.6M |
-$5.91M |
ABBV, DD, UTHR, JNJ, VZ
|
13F-HR |
2/9/2015, 02:38 PM |
Q3 2014 |
81 |
$256M |
+$23.7M |
-$11.4M |
+$12.3M |
MSFT, UTHR, ABBV, VZ, DD
|
13F-HR |
11/10/2014, 02:40 PM |
Q2 2014 |
80 |
$246M |
+$28.5M |
-$34.6M |
-$6.07M |
MSFT, DMLP, CIOXY, GSK, VZ
|
13F-HR |
8/6/2014, 02:47 PM |
Q1 2014 |
83 |
$247M |
+$30.1M |
-$30.4M |
-$277K |
MSFT, GSK, DMLP, VZ, DD
|
13F-HR |
5/6/2014, 12:47 PM |
Q4 2013 |
82 |
$248M |
$0 |
$0 |
|
MSFT, GSK, DMLP, VOD, AMGZO
|
13F-HR |
2/11/2014, 01:10 PM |